The results of Danshen and its lively parts (tanshinone I, tanshinone IIA, dihydrotanshinone and cryptotanshinone) on tolbutamide 4-hydroxylation was investigated within the rat. Danshen (0.125-2mg/ml) decreased 4-hydroxy-tolbutamide formation in vitro and in vivo. Enzyme kinetics research confirmed that inhibition of tolbutamide 4-hydroxylase exercise was aggressive and concentration-dependent. The Ok(i) values of the tanshinones have been: dihydrotanshinone (8.92microM), cryptotanshinone (24.5microM), tanshinone I (80.3microM) and tanshinone IIA (242.9microM). In freshly ready main rat hepatocytes, tanshinones inhibited tolbutamide 4-hydroxylation in a concentration-dependent method, with EC(40) values within the order: cryptotanshinone (15.8microM), tanshinone IIA (16.2microM), dihydrotanshinone (20.1microM) and tanshinone I (48.2microM).
In entire animal research, single dose Danshen remedy (50 or 200mg/kg, i.p.) elevated tolbutamide clearance (17-26.9%), decreased AUC (14.4-20.9%) and elevated the Vd (7.26%). Three-day Danshen remedy (200mg/kg/day, i.p.) decreased the C(preliminary), elevated T(half of) and Vd however didn’t have an effect on tolbutamide clearance and AUC. Tolbutamide-4-hydroxylation in vivo was decreased by Danshen after acute and after 3-day remedy, with decreases within the AUC of 4-hydroxy-tolbutamide (15-28%) over the time interval studied. Regardless of aggressive inhibition of rat CYP2C11 in vitro and in vivo, as proven by the lower in tolbutamide 4-hydroxylation, solely minor modifications in tolbutamide pharmacokinetics was noticed.
Earlier research advised that lamotrigene (LTG) underwent bioactivation to a reactive aryl epoxide intermediate in rats. However, definitive constructions of those thioether conjugates, which are sometimes wanted to substantiate the mechanism of bioactivation and id of reactive intermediate(s), weren’t absolutely established. Within the current examine, GSH, cysteinylglycine, and N-acetyl cysteine conjugates of LTG have been remoted from bile of rats orally dosed with LTG (100 mg/kg), and their constructions have been absolutely elucidated by LC/MS and NMR.
The definitive structural characterization of those metabolites supplied proof for the existence of a reactive aryl epoxide that was trapped as a GSH adduct. In vitro research utilizing varied hepatic mobile and subcellular fractions obtained from human and rat have been carried out to reveal that LTG underwent bioactivation to type a GSH conjugate that was equivalent to the one initially characterised from in vivo research. This examine illustrated that the herb-drug interplay potential must be monitored by each in vitro and in vivo biotransformation/ pharmacokinetic parameters.
In vitro glucuronidation of two,2-bis(bromomethyl)-1,3-propanediol by microsomes and hepatocytes from rats and people.
2,2-Bis(bromomethyl)-1,3-propanediol (BMP) is a brominated flame retardant utilized in unsaturated polyester resins. In a 2-year bioassay BMP was proven to be a multisite carcinogen in rats and mice. As a result of glucuronidation is the important thing metabolic transformation of BMP by rats, on this examine the in vitro hepatic glucuronidation of BMP was in contrast throughout a number of species. As well as, the glucuronidation actions of human intestinal microsomes and particular human hepatic UDP-glucuronosyltransferase (UGT) enzymes for BMP have been decided. To discover different potential routes of metabolism for BMP, research have been performed with rat and human hepatocytes.
Incubation of hepatic microsomes with BMP within the presence of UDP-glucuronic acid resulted within the formation of a BMP monoglucuronide. The order of hepatic microsomal glucuronidation exercise of BMP was rats, mice>>) hamsters>> monkeys>>>> people. The speed of glucuronidation by rat hepatic microsomes was 90-fold larger than that of human hepatic microsomes. Human intestinal microsomes transformed BMP to BMP glucuronide at a charge even decrease than that of human hepatic microsomes. Among the many human UGT enzymes examined, solely UGT2B7 had detectable glucuronidation exercise for BMP.

BMP monoglucuronide was the one metabolite fashioned when BMP was incubated with suspensions of freshly remoted hepatocytes from male F-344 rats or with cryopreserved human hepatocytes. Glucuronidation of BMP in human hepatocytes was extraordinarily low. General, the outcomes assist in vivo research in rats by which BMP glucuronide was the one metabolite discovered. The poor glucuronidation capability of people for BMP means that the pharmacokinetic profile of BMP in people shall be dramatically completely different from that of rodents.
Clearance and clearance inhibition of the HIV-1 protease inhibitors ritonavir and saquinavir in sandwich-cultured rat hepatocytes and rat microsomes.
The metabolism and lively transport of ritonavir and saquinavir have been studied utilizing sandwich-cultured rat hepatoyctes and rat liver microsomes. For ritonavir 4 comparable metabolites have been noticed within the sandwich-culture and in microsomes. For saquinavir eight metabolites have been noticed in sandwich-culture and 14 completely different metabolites in microsomes. Ketoconazole didn’t have an effect on the metabolism of ritonavir in sandwich-culture or microsomes and barely inhibited the metabolism of saquinavir in sandwich-culture. This inhibition resulted in a distinct metabolite profile for saquinavir in microsomes. Ritonavir had a pronounced inhibiting impact on the metabolism of saquinavir and affected the hydroxylation of 6beta-testosterone negatively.
Within the lively transport research, cyclosporin A and PSC833 enhanced the metabolism of ritonavir, suggesting that ritonavir is generally excreted into the bile canaliculi. Verapamil, confirmed no impact on the metabolism of ritonavir. The intrinsic clearance was estimated at 1.65 and 67.5 microl/min/1 x 10(6) cells and the hepatic metabolism clearance at 0.017 and 6.83ml/min/SRW for ritonavir and saquinavir respectively. In conclusion, for saquinavir the metabolism charge and the quantity of metabolites produced was greater than for ritonavir.
Bovine 6-phosphofructokinase, liver type(PFKL)ELISA kit |
YLA0245BO-96T |
Shanghai YL Biotech |
96T |
EUR 618.75 |
Liver Liver Cirrhosis Lysate |
XBL-10358 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human liver tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Bovine FABP1/ Fatty acid-binding protein, liver ELISA Kit |
E0092Bo |
Sunlong |
1 Kit |
EUR 860.4 |
ELISA kit for Bovine Fatty acid-binding protein, liver |
EK4389 |
SAB |
96 tests |
EUR 703.2 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Bovine Fatty acid-binding protein, liver in samples from serum, plasma, tissue homogenates and other biological fluids. |
ELISA kit for Bovine Glycogen phosphorylase, liver form (PYGL) |
KTE10142-48T |
Abbkine |
48T |
EUR 424.8 |
|
Description: Quantitative sandwich ELISA for measuring Bovine Glycogen phosphorylase, liver form (PYGL) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Bovine Glycogen phosphorylase, liver form (PYGL) |
KTE10142-5platesof96wells |
Abbkine |
5 plates of 96 wells |
EUR 2702.4 |
|
Description: Quantitative sandwich ELISA for measuring Bovine Glycogen phosphorylase, liver form (PYGL) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
ELISA kit for Bovine Glycogen phosphorylase, liver form (PYGL) |
KTE10142-96T |
Abbkine |
96T |
EUR 686.4 |
|
Description: Quantitative sandwich ELISA for measuring Bovine Glycogen phosphorylase, liver form (PYGL) in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
LEAP2 ELISA Kit| Bovine Liver-expressed antimicrobial peptide 2 |
EF011562 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Bovine Fatty acid- binding protein, liver, FABP1 ELISA KIT |
ELI-07065b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Bovine Liver- expressed antimicrobial peptide 2, LEAP2 ELISA KIT |
ELI-20184b |
Lifescience Market |
96 Tests |
EUR 1113.6 |
Liver X Receptor Alpha (LXRa) Polyclonal Antibody (Bovine), APC |
4-PAC044Bo01-APC |
Cloud-Clone |
-
EUR 466.80
-
EUR 4686.00
-
EUR 1284.00
-
EUR 603.60
-
EUR 285.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Liver X Receptor Alpha (LXRa). This antibody is labeled with APC. |
Liver X Receptor Alpha (LXRa) Polyclonal Antibody (Bovine), Biotinylated |
4-PAC044Bo01-Biotin |
Cloud-Clone |
-
EUR 412.80
-
EUR 3506.40
-
EUR 1011.60
-
EUR 512.40
-
EUR 279.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Liver X Receptor Alpha (LXRa). This antibody is labeled with Biotin. |
Liver X Receptor Alpha (LXRa) Polyclonal Antibody (Bovine), Cy3 |
4-PAC044Bo01-Cy3 |
Cloud-Clone |
-
EUR 572.40
-
EUR 6198.00
-
EUR 1662.00
-
EUR 754.80
-
EUR 331.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Liver X Receptor Alpha (LXRa). This antibody is labeled with Cy3. |
Liver X Receptor Alpha (LXRa) Polyclonal Antibody (Bovine), FITC |
4-PAC044Bo01-FITC |
Cloud-Clone |
-
EUR 397.20
-
EUR 3772.80
-
EUR 1051.20
-
EUR 506.40
-
EUR 252.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Liver X Receptor Alpha (LXRa). This antibody is labeled with FITC. |
Liver X Receptor Alpha (LXRa) Polyclonal Antibody (Bovine), HRP |
4-PAC044Bo01-HRP |
Cloud-Clone |
-
EUR 424.80
-
EUR 4081.20
-
EUR 1132.80
-
EUR 542.40
-
EUR 267.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Liver X Receptor Alpha (LXRa). This antibody is labeled with HRP. |
Liver X Receptor Alpha (LXRa) Polyclonal Antibody (Bovine), PE |
4-PAC044Bo01-PE |
Cloud-Clone |
-
EUR 397.20
-
EUR 3772.80
-
EUR 1051.20
-
EUR 506.40
-
EUR 252.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Liver X Receptor Alpha (LXRa). This antibody is labeled with PE. |
cDNA from Liver Cirrhosis: Liver |
C1236149Lcs |
Biochain |
40 reactions |
EUR 801.6 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
Liver Membrane Liver Cirrhosis Lysate |
XBL-10671 |
ProSci |
0.1 mg |
EUR 752.1 |
Description: Human liver tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human liver tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated liver tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated liver tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
Bovine L-FABP(Liver Fatty acid Binding Protein) ELISA Kit |
EB0095 |
FN Test |
96T |
EUR 681.12 |
|
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Cattle;Sensitivity: 0.469 ng/ml |
Fatty Acid Binding Protein 1, Liver (FABP1) Polyclonal Antibody (Bovine) |
4-PAB566Bo01 |
Cloud-Clone |
-
EUR 320.40
-
EUR 3391.20
-
EUR 836.40
-
EUR 405.60
-
EUR 266.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Fatty Acid Binding Protein 1, Liver (FABP1) |
Liver X Receptor Alpha (LXRa) Polyclonal Antibody (Bovine), APC-Cy7 |
4-PAC044Bo01-APC-Cy7 |
Cloud-Clone |
-
EUR 790.80
-
EUR 9228.00
-
EUR 2424.00
-
EUR 1063.20
-
EUR 427.20
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Liver X Receptor Alpha (LXRa). This antibody is labeled with APC-Cy7. |
Total Protein from Liver Cirrhosis: Liver |
P1236149Lcs |
Biochain |
1 mg |
EUR 553.2 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
Membrane Protein from Liver Cirrhosis: Liver |
P3236149Lcs |
Biochain |
0.1 mg |
EUR 489.6 |
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
Total RNA from Liver Cirrhosis: Liver |
R1236149Lcs-50 |
Biochain |
50 ug |
EUR 421.2 |
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
Paraffin Tissue Section - Liver Cirrhosis: Liver |
T2236149Lcs |
Biochain |
5 slides |
EUR 308.4 |
Description: Our tissue products are produced by strictly following the IRB ethical standards and procedures and from highest quality tissues. Immediately after collection the tissues are placed in liquid nitrogen and examined by certified pathologists. The thickness of each individual section is ~5um. They are Hematoxylin and Eosin stained and quality tested by immunostaining with anti-beta-actin antibodies. Our tissue products are suitable for various studies on cellular level (RNA localization, Protein expression, etc.) on both normal and pathological cases. It is also an excellent control and educational tool. |
Liver cancer and liver tissue array |
BC03116a |
TissueArray |
each |
EUR 306 |
Description: Liver cancer and liver tissue array, including pathology grade, TNM and clinical stage, 70 cases/70 cores, replacing BC03116 |
Liver cancer with liver tissue array |
LV1021a |
TissueArray |
each |
EUR 204 |
Description: Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores, replacing LV1021 |
Liver cancer with liver tissue array |
LV243 |
TissueArray |
each |
EUR 66 |
Description: Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores |
Liver cancer with liver tissue array |
LV722 |
TissueArray |
each |
EUR 306 |
Description: Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing LV721 |
Liver cancer with liver tissue array |
LV803b |
TissueArray |
each |
EUR 270 |
Description: Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 54 cases/72 cores, replacing LV803a |
Liver tumor with liver tissue array |
T032d |
TissueArray |
each |
EUR 48 |
Description: Liver tumor with liver tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T032c |
Liver Lysate |
21-105 |
ProSci |
0.1 mg |
EUR 342.6 |
Description: Bovine liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The bovine liver tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Liver Lysate |
21-406 |
ProSci |
0.1 mg |
EUR 342.6 |
Description: Porcine liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The porcine liver tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Liver Lysate |
21-419 |
ProSci |
0.1 mg |
EUR 342.6 |
Description: Rabbit liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The rabbit liver tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Liver Lysate |
1464 |
ProSci |
0.1 mg |
EUR 229.2 |
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
Liver cancer |
BC03117 |
TissueArray |
each |
EUR 306 |
Description: Liver cancer, liver cirrhosis tissue array with normal tissue as control, including TNM, clinical stage, pathology grade and history of hepatitis, 70 cases/ 80 cores, replaced by BC03117a |
Liver tissue |
LV805b |
TissueArray |
each |
EUR 270 |
Description: Liver tissue, hepatitis and cirrhosis tissue array, 80 cases/80 cores, replacing LV805a |
50ml TC Tubes, Conical, 440 units/box |
04-5540150 |
Gentaur Genprice |
440 units/box |
EUR 85.2 |
GMP IL4, 50µg |
04-GMP-HU-IL4-50UG |
Gentaur Genprice |
50µg |
EUR 579.6 |
Description: Recombinant Human IL-4 produced in E.Coli is a single, non-glycosylated polypeptide chain containing 130 amino acids and having a molecular mass of 15000 Dalton. The rHuIL-4 is purified by proprietary chromatographic techniques. |
rHu IL 2 , 3MIU |
04-RHIL2-02F01 |
Gentaur Genprice |
1 vial |
EUR 298.8 |
Description: Recombinant human interleukin-2 is a sterile protein product for injection. rHuIL-2 is produced by recombinant DNA technology using Yeast. It is a highly purified protein containing 133 amino acids, with cysteine mutated to alanine at 125 amino acid position, and has a molecular weight of approximately 15.4kD, non-glycosylated. |
rHu IL 2 , 3MIU , Lot 200908F02 |
04-RHIL2-08F02 |
Gentaur Genprice |
1 vial |
EUR 298.8 |
Description: Recombinant human interleukin-2 is a sterile protein product for injection. rHuIL-2 is produced by recombinant DNA technology using Yeast. It is a highly purified protein containing 133 amino acids, with cysteine mutated to alanine at 125 amino acid position, and has a molecular weight of approximately 15.4kD, non-glycosylated. |
PRE-GMP rHu GM-CSF, Molgramostim-Leukoma |
04-RHUGM-CSF-7A10 |
Gentaur Genprice |
300 µg |
EUR 462 |
Description: Recombinant human GM-CSF produced in E.coli is a single, non-glycosylated, polypeptide chain containing 127 amino acids, two pairs of disulfide bonds and having a molecular mass of approximately 14.5kD. |
Monkeypox Virus Real Time PCR Kit |
ZD-0076-01 |
Gentaur Genprice |
25 tests/kit |
Ask for price |
|
Description: Monkeypox virus is the virus that causes the disease monkeypox in both humans and animals. Monkeypox virus is an Orthopoxvirus, a genus of the family Poxviridae that contains other viral species that target mammals. The virus is mainly found in tropical rainforest regions of central and West Africa. The primary route of infection is thought to be contact with the infected animals or their bodily fluids. The genome is not segmented and contains a single molecule of linear double-stranded DNA, 185000 nucleotides long. The Monkeypox Virus real time PCR Kit contains a specific ready-to-use system for the detection of the Monkeypox Virusthrough polymerase chain reaction (PCR) in the real-time PCR system. The master contains reagents and enzymes for the specific amplification of the Monkeypox Virus DNA. Fluorescence is emitted and measured by the real time systems ́ optical unit during the PCR. The detection of amplified Monkeypox Virus DNA fragment is performed in fluorimeter channel 530nm with the fluorescent quencher BHQ1. DNA extraction buffer is available in the kit and serum or lesion exudate samples are used for the extraction of the DNA. In addition, the kit contains a system to identify possible PCR inhibition by measuring the 560nm fluorescence of the internal control (IC). An external positive control defined as 1×10^7 copies/ml is supplied which allow the determination of the gene load. |
Monkeypox Virus Real Time PCR Kit |
ZD-0076-02 |
Gentaur Genprice |
25 tests/kit |
Ask for price |
|
Description: Monkeypox virus is the virus that causes the disease monkeypox in both humans and animals. Monkeypox virus is an Orthopoxvirus, a genus of the family Poxviridae that contains other viral species that target mammals. The virus is mainly found in tropical rainforest regions of central and West Africa. The primary route of infection is thought to be contact with the infected animals or their bodily fluids.The genome is not segmented and contains a single molecule of linear double-stranded DNA, 185000 nucleotides long.The Monkeypox Virus real time PCR Kit contains a specific ready-to-use system for the detection of the Monkeypox Virusthrough polymerase chain reaction (PCR) in the real-time PCR system. The master contains reagents and enzymes for the specific amplification of theMonkeypox VirusDNA. Fluorescence is emitted and measured by the real time systems ́ optical unit during the PCR. The detection of amplified Monkeypox Virus DNA fragment is performed in fluorimeter channelFAM with the fluorescent quencher BHQ1. DNA extraction buffer is available in the kit and serum or lesion exudate samples are used for the extraction of the DNA. In addition, the kit contains a system to identify possible PCR inhibition by measuring the HEX/VIC/JOE fluorescence of the internal control (IC). An external positive control defined as 1×107copies/ml is supplied which allow the determination of the gene load. |
Exo-Check Exosome Antibody Array |
322-EXO-FBS-50A-1 |
Gentaur Genprice |
100 µg |
EUR 469.2 |
1-Step Polymorphs, Human Cell Separation |
71-AN221725 |
Gentaur Genprice |
1 |
EUR 238.8 |
Porcine Parvovirus Antibody Elisa Test Kit |
767-LSY-30009 |
Gentaur Genprice |
192 Wells/kit |
EUR 382 |
SDS-Blue™ - Coomassie based solution for protein staining in SDS-PAGE |
04-GSB |
Gentaur Genprice |
|
|
|
Description: SDS-Blue™ is an innovative patented formula, based on Coomassie blue, that comes in a convenient ready to use format for staining proteins in SDS-PAGE (sodium dodecyl sulphate–polyacrylamide gel electrophoresis). The formulation of SDS-Blue™ provides numerous advantages compared to the classic Coomassie staining or to other similar protein stains. SDS-Blue™ provides higher sensitivity, virtually no background and eliminates the need for destaining of the gel due to its high specificity and affinity to bind to protein only. Not only does SDS-Blue™ yield clear and sharp bands, but it also contains no methanol and acetic acid, making it non-hazardous, safe to handle and friendly to the environment when disposed of. Two other advantages that make SDS-Blue™ the better option is that it is not light sensitive and can be stored at ambient temperature for 24 months. And this provides a considerable convenience, especially to laboratories that need and keep big amount of protein staining solutions – no more jammed refrigerators, you can keep SDS-Blue™ wherever it is most convenient for You! |
Malachite Green Phosphate Assay kit |
65-POMG-25H |
Gentaur Genprice |
2500 tests |
EUR 333 |
Liver cancer with matched liver tissue array |
LV241b |
TissueArray |
each |
EUR 66 |
Description: Liver cancer with matched liver tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing LV241a |
Liver cancer and normal liver tissue array |
LV483a |
TissueArray |
each |
EUR 198 |
Description: Liver cancer and normal liver tissue array, including hepatocellular carcinoma,cholangiocellular carcinoma and normal tissues pathology grade, TNM and clinical stage (AJCC 7th edition), 48 cases/48 cores (core size 1.5mm), replacing LV483 |
Multiple liver disease with liver tissue array |
LV601 |
TissueArray |
each |
EUR 306 |
Description: Multiple liver disease with liver tissue array, including pathology grade, TNM and clinical stage (reference AJCC 8th version), 46 cases/60 cores |
L-FABP ELISA Kit| Bovine Liver Fatty acid Binding Protein ELISA |
EF011047 |
Lifescience Market |
96 Tests |
EUR 826.8 |
Fatty Acid Binding Protein 1, Liver (FABP1) Polyclonal Antibody (Bovine), APC |
4-PAB566Bo01-APC |
Cloud-Clone |
-
EUR 451.20
-
EUR 4448.40
-
EUR 1224.00
-
EUR 579.60
-
EUR 278.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Fatty Acid Binding Protein 1, Liver (FABP1). This antibody is labeled with APC. |
Fatty Acid Binding Protein 1, Liver (FABP1) Polyclonal Antibody (Bovine), Biotinylated |
4-PAB566Bo01-Biotin |
Cloud-Clone |
-
EUR 400.80
-
EUR 3331.20
-
EUR 967.20
-
EUR 494.40
-
EUR 273.60
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Fatty Acid Binding Protein 1, Liver (FABP1). This antibody is labeled with Biotin. |
Fatty Acid Binding Protein 1, Liver (FABP1) Polyclonal Antibody (Bovine), Cy3 |
4-PAB566Bo01-Cy3 |
Cloud-Clone |
-
EUR 550.80
-
EUR 5881.20
-
EUR 1582.80
-
EUR 722.40
-
EUR 320.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Fatty Acid Binding Protein 1, Liver (FABP1). This antibody is labeled with Cy3. |
Fatty Acid Binding Protein 1, Liver (FABP1) Polyclonal Antibody (Bovine), FITC |
4-PAB566Bo01-FITC |
Cloud-Clone |
-
EUR 384.00
-
EUR 3582.00
-
EUR 1003.20
-
EUR 487.20
-
EUR 246.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Fatty Acid Binding Protein 1, Liver (FABP1). This antibody is labeled with FITC. |
Fatty Acid Binding Protein 1, Liver (FABP1) Polyclonal Antibody (Bovine), HRP |
4-PAB566Bo01-HRP |
Cloud-Clone |
-
EUR 410.40
-
EUR 3874.80
-
EUR 1081.20
-
EUR 522.00
-
EUR 260.40
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Fatty Acid Binding Protein 1, Liver (FABP1). This antibody is labeled with HRP. |
Fatty Acid Binding Protein 1, Liver (FABP1) Polyclonal Antibody (Bovine), PE |
4-PAB566Bo01-PE |
Cloud-Clone |
-
EUR 384.00
-
EUR 3582.00
-
EUR 1003.20
-
EUR 487.20
-
EUR 246.00
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Fatty Acid Binding Protein 1, Liver (FABP1). This antibody is labeled with PE. |
Bovine Liver Type Fatty Acid Binding Protein(L-FABP) ELISA KIT |
YLA0328BO-48T |
Shanghai YL Biotech |
48T |
EUR 502.5 |
Bovine Liver Type Fatty Acid Binding Protein(L-FABP) ELISA KIT |
YLA0328BO-96T |
Shanghai YL Biotech |
96T |
EUR 618.75 |
Hepatitis B liver cancer and liver tissue array |
LV1401 |
TissueArray |
each |
EUR 474 |
Description: Hepatitis B liver cancer and liver tissue array, including pathology grade, TNM, clinical stage and HBV data, 99 cases/140 cores |
High density liver cancer with liver tissue array |
LV208 |
TissueArray |
each |
EUR 546 |
Description: High density liver cancer with liver tissue array, including pathology grade, TNM and clinical stage., 69 cases/207 cores |
High density liver cancer with liver tissue array |
LV2091 |
TissueArray |
each |
EUR 474 |
Description: High density liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 208 cases/208 cores |
Liver cancer with adjacent normal liver tissue array |
LV242a |
TissueArray |
each |
EUR 66 |
Description: Liver cancer with adjacent normal liver tissue array, including pathology grade, TNM and clinical stage (reference AJCC 7th version), 12 cases/24 cores, replacing LV242 |
Liver cancer and normal adjacent liver tissue array |
LV801b |
TissueArray |
each |
EUR 306 |
Description: Liver cancer and normal adjacent liver tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores (1.5mm), replacing LV801a |
Chang Liver (HeLa) |
C0050007 |
Addexbio |
One Frozen vial |
EUR 651.6 |
Liver Arginase Antibody |
49867-100ul |
SAB |
100ul |
EUR 399.6 |
Liver Arginase Antibody |
49867-50ul |
SAB |
50ul |
EUR 286.8 |
CK LIVER 1kg* |
43023-2 |
Pel-Freez |
1 kg |
EUR 288.11 |
Ferritin protein (Liver) |
30-AF10 |
Fitzgerald |
1 mg |
EUR 369.6 |
Description: Highly purfied Ferritin protein isolated from human liver |
Liver Tumor Lysate |
1330 |
ProSci |
0.1 mg |
EUR 304.8 |
Description: Liver tumor tissue lysate was prepared by homogenization in lysis buffer (10 mM HEPES pH7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM ethylenediaminetetraacetic acid, 10% glycerol, 1% NP-40, and a cocktail of protease inhibitors). Tissue and cell debris was removed by centrifugation. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
Liver Ferritin Protein |
20-abx260074 |
Abbexa |
-
EUR 3483.60
-
EUR 777.60
-
EUR 343.20
|
|
|
liver Arginase Antibody |
abx234800-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
liver Arginase Antibody |
abx234801-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
anti-liver Arginase |
YF-PA10306 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to liver Arginase |
anti-liver Arginase |
YF-PA10307 |
Abfrontier |
50 ug |
EUR 435.6 |
Description: Mouse polyclonal to liver Arginase |
anti-liver Arginase |
YF-PA10308 |
Abfrontier |
100 ul |
EUR 483.6 |
Description: Rabbit polyclonal to liver Arginase |
anti-liver Arginase |
YF-PA10309 |
Abfrontier |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal to liver Arginase |
anti-liver FABP |
YF-PA11679 |
Abfrontier |
50 ul |
EUR 435.6 |
Description: Mouse polyclonal to liver FABP |
anti-liver FABP |
YF-PA11680 |
Abfrontier |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal to liver FABP |
anti-liver FABP |
YF-PA11681 |
Abfrontier |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal to liver FABP |
anti-liver FABP |
YF-PA23687 |
Abfrontier |
50 ul |
EUR 400.8 |
Description: Mouse polyclonal to liver FABP |
Liver Lupus Lysate |
XBL-10359 |
ProSci |
0.1 mg |
EUR 796.2 |
Description: Human liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human liver tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Fetal Liver Lysate |
XBL-10409 |
ProSci |
0.1 mg |
EUR 342.6 |
Description: Fetal human liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human liver tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
Liver Cytoplasmic Lysate |
XBL-10666 |
ProSci |
0.1 mg |
EUR 273.3 |
Description: Human liver tissue cytoplasmic protein lysate was prepared by isolating the cytoplasmic protein from whole tissue homogenates using a proprietary technique. The human liver tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The cytoplasmic protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, glycerol, and a cocktail of protease inhibitors. For quality control purposes, the isolated liver tissue cytoplasmic protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated liver tissue cytoplasmic protein is then Western analyzed by GAPDH antibody, and the expression level is consistent with each lot. |
Liver Membrane Lysate |
XBL-10667 |
ProSci |
0.1 mg |
EUR 619.8 |
Description: Human liver tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human liver tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated liver tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated liver tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
Ferritin, Human liver |
P1449-100 |
Biovision |
each |
EUR 196.8 |
Fatty Acid Binding Protein 1, Liver (FABP1) Polyclonal Antibody (Bovine), APC-Cy7 |
4-PAB566Bo01-APC-Cy7 |
Cloud-Clone |
-
EUR 758.40
-
EUR 8752.80
-
EUR 2305.20
-
EUR 1015.20
-
EUR 412.80
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Bovine Fatty Acid Binding Protein 1, Liver (FABP1). This antibody is labeled with APC-Cy7. |
Liver cancer with matched cancer adjacent liver tissue array |
LV1505a |
TissueArray |
each |
EUR 258 |
Description: Liver cancer with matched cancer adjacent liver tissue array, including pathology grade, TNM and clinical stage, replacing LV1505 |
Different stages of liver cancer and liver tissue array |
LV808 |
TissueArray |
each |
EUR 306 |
Description: Different stages of liver cancer and liver tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores |
Genomic DNA from Liver Cirrhosis: Liver, from a single donor |
D1236149Lcs |
Biochain |
50 ug |
EUR 535.2 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
Liver cancer and matched liver tissue array with drinking history |
LV248a |
TissueArray |
each |
EUR 114 |
Description: Liver cancer and matched liver tissue array with drinking history, including pathology grade, TNM and clinical stage, 12 cases/24 cores, (1.5mm), replacingLV248 |
Liver disease spectrum (hepatic cancer progression) and liver tissue array |
LV8011b |
TissueArray |
each |
EUR 306 |
Description: Liver disease spectrum (hepatic cancer progression) and liver tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replacing LV8011a |
Liver cancer tissue array with normal liver tissue as control |
T033b |
TissueArray |
each |
EUR 66 |
Description: Liver cancer tissue array with normal liver tissue as control, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/ 24 cores, replacing T033a |
cDNA from Lupus: Liver |
C1236149Lup |
Biochain |
40 reactions |
EUR 801.6 |
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
Liver Canuliculi(HSA98) Antibody |
BNCA0098-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Liver Canuliculi(HSA98), APC conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNCAP0098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNCAP0098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC610098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF660R conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC610098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF660R conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC680098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF568 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC680098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF568 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNCR0098-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Liver Canuliculi(HSA98), RPE conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNUB0098-100 |
Biotium |
100uL |
EUR 250.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), Concentration: 0.2mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNUB0098-500 |
Biotium |
500uL |
EUR 549.6 |
Description: Primary antibody against Liver Canuliculi(HSA98), Concentration: 0.2mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC430098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF543 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC430098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF543 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC470098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF647 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC470098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF647 conjugate, Concentration: 0.1mg/mL |
Liver Arginase Conjugated Antibody |
C49867 |
SAB |
100ul |
EUR 476.4 |
Liver Canuliculi(HSA98) Antibody |
BNC400098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF640R conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC400098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF640R conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC880098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF488A conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC880098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF488A conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC810098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF680R conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC810098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF680R conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNCP0098-250 |
Biotium |
250uL |
EUR 459.6 |
Description: Primary antibody against Liver Canuliculi(HSA98), PerCP conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNUM0098-50 |
Biotium |
50uL |
EUR 474 |
Description: Primary antibody against Liver Canuliculi(HSA98), 1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC050098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF405M conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC050098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF405M conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC700098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF770 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC700098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF770 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC800098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF680 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC800098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF680 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNCB0098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), Biotin conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNCB0098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), Biotin conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC940098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF594 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC940098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF594 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC550098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF555 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC550098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF555 conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNCH0098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNCH0098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
anti- liver Arginase antibody |
FNab04800 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against liver Arginase |
anti- liver Arginase antibody |
FNab04801 |
FN Test |
100µg |
EUR 606.3 |
|
Description: Antibody raised against liver Arginase |
PG LIVER 2 EA* |
59423-2 |
Pel-Freez |
2 EA |
EUR 230.69 |
Liver X Receptor Peptide |
45-100P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: (IN) Liver X Receptor / LXR alpha / LXR beta Peptide |
Recombinant Human Arginase, Liver |
7-02482 |
CHI Scientific |
5µg |
Ask for price |
Recombinant Human Arginase, Liver |
7-02483 |
CHI Scientific |
25µg |
Ask for price |
Recombinant Human Arginase, Liver |
7-02484 |
CHI Scientific |
1mg |
Ask for price |
FABP protein (liver specific) |
30R-2618 |
Fitzgerald |
25 ug |
EUR 295.2 |
Description: Purified recombinant Human FABP1 protein |
Chicken Liver Tissue Lysate |
30R-AC011 |
Fitzgerald |
150 ug |
EUR 230.4 |
Description: Freshly prepared tissue lysate isolated from liver of normal chicken |
Rabbit Liver Tissue Lysate |
30R-AL003 |
Fitzgerald |
150 ug |
EUR 302.4 |
Description: Fresh tissue lysate prepared from rabbit liver |
Rabbit LIVER 20 EA |
41223-2 |
Pel-Freez |
20 EA |
EUR 196.75 |
Mouse Liver PrimaCell: Hepatocytes |
2-82100 |
CHI Scientific |
1 Kit |
Ask for price |
Rat Liver PrimaCell: Hepatocytes |
2-82595 |
CHI Scientific |
1 Kit |
Ask for price |
Human Liver PrimaCell: Hepatocytes |
2-96121 |
CHI Scientific |
1 Kit |
Ask for price |
Human Ferritin (Liver) Antibody |
11321-05011 |
AssayPro |
150 ug |
EUR 260.4 |
Liver Tissue Lysate (Normal) |
1718-01 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Liver Tissue Lysate (Normal) |
1718-02 |
ProSci |
0.1 mg |
EUR 260.7 |
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Liver Tissue Lysate (Tumor) |
1719-01 |
ProSci |
0.1 mg |
EUR 336.3 |
Description: Liver tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Liver Tissue Lysate (Tumor) |
1719-02 |
ProSci |
0.1 mg |
EUR 336.3 |
Description: Liver tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Liver Tissue Lysate (Tumor) |
1720-01 |
ProSci |
0.1 mg |
EUR 336.3 |
Description: Liver tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
Porcine Liver Esterase protein |
30-1193 |
Fitzgerald |
5 kU |
EUR 380.4 |
Description: Purified native Porcine Porcine Liver Esterase protein |
Liver Tissue Slide (Normal) |
10-201-10um |
ProSci |
10 um |
EUR 241.8 |
Liver Tissue Slide (Normal) |
10-201-4um |
ProSci |
4 um |
EUR 216.6 |
FABP antibody (liver specific) |
10-2287 |
Fitzgerald |
100 ug |
EUR 489.6 |
Description: Recombinant Fab monoclonal FABP antibody (liver specific) |
Liver Tissue Slide (Abnormal) |
10-237-10um |
ProSci |
10 um |
EUR 241.8 |
Liver Tissue Slide (Abnormal) |
10-237-4um |
ProSci |
4 um |
EUR 216.6 |
Rat Ferritin (Liver) Antibody |
11901-05011 |
AssayPro |
150 ug |
EUR 260.4 |
Mouse Ferritin (Liver) Antibody |
11911-05011 |
AssayPro |
150 ug |
EUR 260.4 |
Phosphofructokinase, Liver (PFKL) Antibody |
20-abx174031 |
Abbexa |
|
|
|
Phosphofructokinase, Liver (PFKL) Antibody |
abx146435-100ug |
Abbexa |
100 ug |
EUR 469.2 |
|
Phosphofructokinase, Liver (PFKL) Antibody |
20-abx130089 |
Abbexa |
-
EUR 543.60
-
EUR 159.60
-
EUR 1562.40
-
EUR 744.00
-
EUR 410.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Phosphofructokinase, Liver (PFKL) Antibody |
20-abx114459 |
Abbexa |
|
|
|
Phosphorylase, Glycogen, Liver Antibody |
20-abx114508 |
Abbexa |
|
|
|
Phosphofructokinase, Liver (PFKL) Antibody |
20-abx008875 |
Abbexa |
-
EUR 360.00
-
EUR 526.80
-
EUR 226.80
|
|
|
Human Liver Ferritin Protein |
abx060939-1mg |
Abbexa |
1 mg |
EUR 543.6 |
|
Human Liver Ferritin Protein |
abx060940-1mg |
Abbexa |
1 mg |
EUR 1053.6 |
|
Phosphofructokinase, Liver (PFKL) Antibody |
abx033895-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Phosphofructokinase, Liver (PFKL) Antibody |
abx033895-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Phosphofructokinase, Liver (PFKL) Antibody |
20-abx317882 |
Abbexa |
-
EUR 493.20
-
EUR 2214.00
-
EUR 718.80
-
EUR 218.40
-
EUR 360.00
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Phosphofructokinase, liver (PFKL) Antibody |
20-abx328590 |
Abbexa |
|
|
|
Phosphofructokinase, liver (PFKL) Antibody |
20-abx213788 |
Abbexa |
|
|
|
Phosphofructokinase, Liver (PFKL) Antibody |
abx236340-100ug |
Abbexa |
100 ug |
EUR 577.2 |
|
Liver Canuliculi(HSA98) Antibody |
BNC040098-100 |
Biotium |
100uL |
EUR 238.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF405S conjugate, Concentration: 0.1mg/mL |
Liver Canuliculi(HSA98) Antibody |
BNC040098-500 |
Biotium |
500uL |
EUR 652.8 |
Description: Primary antibody against Liver Canuliculi(HSA98), CF405S conjugate, Concentration: 0.1mg/mL |
Rat Liver Tissue Lysate |
LYSATE0003 |
BosterBio |
200ug |
EUR 180 |
Description: This cell lysate is prepared from rat liver tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
Mouse Liver Tissue Lysate |
LYSATE0013 |
BosterBio |
200ug |
EUR 180 |
Description: This cell lysate is prepared from mouse liver tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
Ritonavir had a powerful inhibitory impact on the metabolism of saquinavir and gave the impression to be excreted into the bile. The precise mechanism liable for GSH depletion is unknown at current. Additional experiments are wanted to completely perceive the consequences of BNZs on the parasite GSH analogue, trypanothione, which can be a direct or oblique goal for these brokers. Pharmacokinetic analysis of those compounds is required to additional progress their improvement as potential new remedies for leishmaniasis.